Marius Pearson

The need for an integrated, multidisciplinary approach to drug development, healthcare policy and decision-making was a recurring theme of the Westminster Business Forum Keynote Seminar on UK health life sciences, attended by Oxford PharmaGenesis this week in Whitehall, London, UK. This strongly supports the HealthScience concept developed by Oxford PharmaGenesis, which combines the clinical and […]

A pioneering systematic methodology to identify observational data sources for specific needs has been presented by Oxford PharmaGenesis today at ISPOR’s 19th Annual International Meeting in Montreal, Canada.

A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

Oxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

Oxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.

Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.

Recent announcements regarding Government investments in Oxfordshire are good news for those working within biosciences in the county.